-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LTrBZ+3mDCcviDfK717bGAMH9wX5erGhxfTmedfgz1bHa+Zu2y3Co5PK7cOf3lVk a6TFRd3EBiij+yBnJ3wqrw== 0001144204-08-047352.txt : 20080814 0001144204-08-047352.hdr.sgml : 20080814 20080814162205 ACCESSION NUMBER: 0001144204-08-047352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080812 FILED AS OF DATE: 20080814 DATE AS OF CHANGE: 20080814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEXMED INC CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 CORPORATE BLVD CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 BUSINESS PHONE: 6092089688 MAIL ADDRESS: STREET 1: 350 CORPORATE BLVD CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tierney David S CENTRAL INDEX KEY: 0001292636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 081019380 BUSINESS ADDRESS: BUSINESS PHONE: (908) 754-2253 MAIL ADDRESS: STREET 1: C/O ABLE LABORATORIES, INC. STREET 2: 6 HOLLYWOOD COURT, CN 1013 CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 4 1 v123418_ex.xml X0303 4 2008-08-12 0 0001017491 NEXMED INC NEXM 0001292636 Tierney David S 89 TWIN RIVERS DRIVE EAST WINDSOR NJ 08520 1 0 0 0 Common Stock 2008-08-12 4 A 0 70320 1.47 A 213752 D On August 12, 2008, the Compensation Committee of the Company's Board of Directors approved a revised compensation package for the non-employee directors for the 2008 calendar year. In lieu of cash compensation, the non-employee directors have opted to receive, and the Board of Directors has approved, a grant of the Company's common stock for the non-employee directors' service on the Board of Directors and on Board committees during the 2008 calendar year. The price per share (the "Price") is the average of the closing price of the Company's common stock over five consecutive trading days, commencing on January 2, 2008. The number of shares granted was calculated based on the amount of cash the non-employee director would have received for service on the Board and on Board committees, divided by the Price. In accordance with the previous compensation package effective for 2008, 24,324 shares of the Company's common stock were previously granted to each non-employee director and reported on a Form 4. The additional shares granted pursuant to the new compensation package are being reported on this Form 4. /s/ Vivian H. Liu, Attorney in Fact 2008-08-14 -----END PRIVACY-ENHANCED MESSAGE-----